Michael F. Mazurek

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

M. Flint Beal, Neil W. Kowall, David W. Ellison et al. · Nature · 1986 · 1.3K citations

Biochemistry, Natural Sciences, Quinolinic Acid +7

Reduced Numbers of Somatostatin Receptors in the Cerebral Cortex in Alzheimer's Disease

M. Flint Beal, Michael F. Mazurek, Vinh T. Tran et al. · Science · 1985 · 251 citations

Brain Function, Neurochemical Biomarkers, Somatostatin Receptor Concentrations +19

Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease

M. Flint Beal, Michael F. Mazurek, Geetinder K. Chattha et al. · Annals of Neurology · 1986 · 159 citations

A postmortem study of amino acid neurotransmitters in Alzheimer's disease

David W. Ellison, M. Flint Beal, Michael F. Mazurek et al. · Annals of Neurology · 1986 · 138 citations

The Treatment of Neuroleptic Malignant Syndrome are Dantrolene and Bromocriptine Useful Adjuncts to Supportive Care?

Patricia I. Rosebush, Thomas E. Stewart, Michael F. Mazurek · The British Journal of Psychiatry · 1991 · 125 citations

Neuro-oncology, Prolonged Course, Neuroleptic Malignant Syndrome +12